K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord i...

Sector

Healthcare

Industry

Biotechnology

CEO

Fukushima, Komei

Employees

Website

www.kpharma.co.jp

IPO Date

2023-10-17

Headquarters

Tri-Seven Roppongi, 8th Floor, 7-7-7 Roppongi, Minato, Tokyo, 106-0032, Japan

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

K Pharma 4896

K Pharma Earnings Call Summary

K Pharma Earnings

Transcripts

Events

About K Pharma,Inc.

K Pharma
4896